Second Compounding Pharmacy Recalls Products
A Massachusetts pharmacy — also owned by the same executives whose New England Compounding Center (NECC) made tainted steroid injections linked to the massive nationwide meningitis outbreak — has announced a voluntary recall of all its products after a surprise inspection of the facility by federal officials.
Ameridose announced the recall after the U.S. Food and Drug Administration (FDA) raised questions about the sterility of the drugs manufactured at the company's facility, according to The Tennessean. The pharmacy, which supplies drugs to hospitals in Tennessee, had already ceased production at its Massachusetts plant.
No reports of adverse events related to Ameridose products have been reported to the FDA. Ameridose and the FDA both have not identified any impurities in any Ameridose products to date. The recall has been issued as a mark of co-operation with the authorities, reports The Tennessean.
The Centers for Disease Control says that the ongoing fungal meningitis outbreak has sickened close to 400 and killed 28 people in 19 states. Nine joint infections related to the outbreak have also been reported. Around 14,000 patients received the contaminated steroid injections for back or joint pain and are believed at risk of infection.